Keith has another relevant and interesting take on things...
-
-
Seems serious enough. If people really wanted to get involved I am sure they would contact Life Tech for the actual details. That's a lot of commentary just because the rules are not posted on a public website. -
No, you won't get further by asking -- I've registered interest in the contest & had no further information sent. Perhaps, as one commenter supposed, the details will come out later this month, but for anyone seriously considering jumping in that gap is a deterrent.Originally posted by SeqAA View Post
It's also a contrast with other such contests, such as the Archon X-Prize in genomics or Google X-prize for the moon, where the specifications are posted in public both to generate serious interest as well as to invite a lot of commentary. Indeed, I believe what I pointed out just scratches the surface of what will be required to really drive interest in the contest, and posting the rules in public would help flush out the missing pieces early (which is indeed the approach Google is taking).
Crowd-sourcing the crowd-sourcing contest design isn't really a very bad idea!Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment